Purpose: Limited data regarding the cystic fibrosis carrier frequency and mutation detection rate is available for Arab-Americans. We retrospectively determined the frequency of carriers among Arab-Americans undergoing preconception and prenatal carrier screening in our laboratories. Methods: Between October, 2001 and June, 2005, we performed carrier screening on 805 Arab-Americans, testing for at least the original 25 mutations recommended by the American College of Medical Genetics. We compared our results to previously published studies among Arabic cystic fibrosis patients. We also performed diagnostic testing on seven individuals.Results: Seven carriers were identified, with an observed carrier frequency of 1 in 115. The most common mutation we identified was W1282X (57% of the mutations detected), followed by ⌬F508 and R117H. Three of 7 patients with a known or suspected diagnosis had two identifiable mutations, including 1548delG, ⌬F508, W1282X, 2789 ϩ 5GϾA and R170H. Conclusion: The current recommended carrier screening panel includes only six mutations reported among Arabic cystic fibrosis patients, accounting for 37.1% of the mutations identified among this group. The addition of 1548delG, I1234V, H139L and 4010del4 as part of an extended screening panel would increase the detection rate to 66.3%, similar to the mutation detection rates in other races/ethnic groups. Genet Med 2006:8(4):255-258.
Key Words: cystic fibrosis, Arab-American, carrier screeningSince the cloning of the cystic fibrosis (CF) gene in 1989, 1,2,3 more than 1,000 mutations have been identified. 4 Most are extremely rare, often reported in only one family. In 2001, the American College of Medical Genetics (ACMG) and American College of Obstetricians and Gynecologists (ACOG) recommended CF carrier screening using a 25-mutation panel for Caucasians who are pregnant or considering pregnancy. They also recommended that testing be made available to individuals in other races and ethnic groups with a lower CF carrier frequency. 5 The original 25 mutations were chosen because they had a frequency of Ն0.1% in the pan-ethnic U.S. population. 5 This panel was modified in 2004 to 23 mutations. 6 Reliable data exist for the carrier frequency and mutation detection rates among Caucasians, African-Americans, and Hispanic-Americans. This is essential for accurate interpretation and risk assessment used by patients to make informed decisions regarding reproductive options. 6,7 However, there is limited epidemiological data on the frequency of CF and prevalent mutations among Arabic CF patients. Furthermore, there are no published reports describing the outcome of CF carrier screening among Arab-Americans. Detroit, Michigan has one of the largest Arab-American populations. Arab-Americans comprise the third largest population tested in our laboratories, after Caucasians and African-Americans. We report our experience with CF carrier screening among Arab-Americans and compare our results to previously published studies among Arabic CF patients.
MATER...